Regulation of neuropeptide Y gene expression in rat brain.
NPY mRNA expression was studied in rat brain using in situ hybridization and RNA blot analysis. Transsynaptic regulation of NPY gene expression was specifically studied in caudate-putamen and frontoparietal (somatosensory) cortex of rats with unilateral lesion of midbrain dopamine neurons and in sham-injected animals. NPY mRNA expression in these two brain regions and the regulation of midbrain dopamine neurons were compared with that of SOM, PPT, CCK and GAD mRNA expression. Neurons expressing NPY and SOM mRNA showed a similar distribution and the expression of both NPY and SOM appears to be regulated by dopamine in a similar fashion. Following a unilateral dopamine deafferentation, the numerical density of both NPY and SOM mRNA expressing neurons almost doubled in the lesioned rat caudate-putamen with no change in the average grain density over positive neurons. Hence, in the intact caudate-putamen dopamine appears to normally suppress expression of these two neuropeptide genes. An activation of both NPY and SOM mRNA expression in many non- or low-expressing neurons is seen when the level of dopamine is decreased. In the frontoparietal cortex, on the other hand, dopamine appears to stimulate NPY and SOM gene expression. RNA blot analysis shows clear-cut changes of NPY mRNA levels in both caudate-putamen and frontoparietal cortex consistent with the changes observed using in situ hybridization. No evidence was found for a change in CCK mRNA expression by the dopamine deafferentation, while PPT mRNA expression decreased in the deafferented caudate-putamen. Consequently, dopamine exerts dissimilar effects on the expression of different neuropeptide genes, that in turn do not respond in the same way in different brain regions. Indirect evidence is also presented indicating that dopamine regulates NPY mRNA expression in a subpopulation of neurons that possibly also express GAD mRNA, both in caudate-putamen and in frontoparietal cortex.
Lindefors
N
N
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Brené
S
S
Herrera-Marschitz
M
M
Persson
H
H
D000818:Animals; D001921:Brain / Q000502:physiology*; D001931:Brain Mapping; D002421:Caudate Nucleus / Q000502:physiology; D002540:Cerebral Cortex / Q000502:physiology; D002766:Cholecystokinin / Q000235:genetics; D004298:Dopamine / Q000502:physiology; D005786:Gene Expression Regulation; D005968:Glutamate Decarboxylase / Q000235:genetics; D009478:Neuropeptide Y / Q000235:genetics*; D009693:Nucleic Acid Hybridization; D011498:Protein Precursors / Q000235:genetics; D011699:Putamen / Q000502:physiology; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin / Q000235:genetics; D015320:Tachykinins / Q000235:genetics
D009478:Neuropeptide Y; D011498:Protein Precursors; D012333:RNA, Messenger; D015320:Tachykinins; C054618:protachykinin; D013004:Somatostatin; D002766:Cholecystokinin; D005968:Glutamate Decarboxylase; D004298:Dopamine